| 000 | 01891 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250515005846.0 | ||
| 264 | 0 | _c20060105 | |
| 008 | 200601s 0 0 eng d | ||
| 022 | _a0250-7005 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNishishiro, Masayuki | |
| 245 | 0 | 0 |
_aInhibition of LPS-stimulated NO production in mouse macrophage-like cells by azulenequinones. _h[electronic resource] |
| 260 |
_bAnticancer research _c |
||
| 300 |
_a4157-63 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAzulenes _xpharmacology |
| 650 | 0 | 4 |
_aBenzoates _xmetabolism |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCyclic N-Oxides _xmetabolism |
| 650 | 0 | 4 | _aElectron Spin Resonance Spectroscopy |
| 650 | 0 | 4 |
_aFree Radical Scavengers _xpharmacology |
| 650 | 0 | 4 |
_aHydrazines _xmetabolism |
| 650 | 0 | 4 |
_aHypoxanthine _xmetabolism |
| 650 | 0 | 4 |
_aImidazoles _xmetabolism |
| 650 | 0 | 4 |
_aLipopolysaccharides _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMacrophages _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNitric Oxide _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNitric Oxide Donors _xmetabolism |
| 650 | 0 | 4 |
_aNitric Oxide Synthase Type II _xbiosynthesis |
| 650 | 0 | 4 |
_aQuinones _xpharmacology |
| 650 | 0 | 4 |
_aRNA, Messenger _xbiosynthesis |
| 650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
| 650 | 0 | 4 |
_aSuperoxides _xmetabolism |
| 650 | 0 | 4 |
_aXanthine Oxidase _xmetabolism |
| 700 | 1 | _aArikawa, Satomi | |
| 700 | 1 | _aWakabayashi, Hidetsugu | |
| 700 | 1 | _aHashimoto, Ken | |
| 700 | 1 | _aSatoh, Kazue | |
| 700 | 1 | _aYokoyama, Keiko | |
| 700 | 1 | _aUnten, Senwa | |
| 700 | 1 | _aKakuta, Hanzo | |
| 700 | 1 | _aKurihara, Teruo | |
| 700 | 1 | _aMotohashi, Noboru | |
| 700 | 1 | _aSakagami, Hiroshi | |
| 773 | 0 |
_tAnticancer research _gvol. 25 _gno. 6B _gp. 4157-63 |
|
| 999 |
_c15932280 _d15932280 |
||